Embed Size (px)
Citation preview
Optical biopsy
Leading edge skin cancer
diagnostics
Fact file
• Founded 2006 on
founder
investment
• HQ in London,
subsidiaries in USA
and Munich; 21
staff
• VivoSight scanner
has FDA, CE &
TGA regulatory
clearance
• $1M sales in 2013,
installed base of
>50 units
“To develop MultiBeam OCT technology into a
viable medical imaging tool”
Optical Coherence
Tomography“Optical Ultrasound”
Low power “eye-safe” infrared light
+
High-power optical amplification
=
Exquisite detail at unparalleled depth,
non-invasively
1991
2002
2n
d g
en
eratio
n
1996 Cardiology
Dermatology
2010
1stg
en
eratio
n
Ophthalmology
What is OTC
OCT
Ultrasound
MRI
What is OCT
Developments
• MultiBeam OCT
• Multichannel detection
• Multichannel digitization
• Next gen lasers
Funding
• Innovate
• Framework 7
• NIHR i4i
Everything about
VivoSight OCT is
developed maximize image contrast.
VivoSight OCT Solution:• Fast and efficient
• Quantified exact measurement documenting extent of invasion
• Safe, painless, reliable
• Enables monitoring of treatment progress
• The clinician makes the decision, not the scanner
• Improves patients’ satisfaction and empowerment
2mm
Tumour
www.vivosight atlas.com
Key Applications
Diagnosis Staging
Presurgical margin-mappingNon-invasive treament
monitoring
Non-melanomaskin cancer
Other areas
• Microneedle
development
• Wound and burn
healing
• Vascular studies
(angiography)
• Rheumatology
• Longitudinal cosmetic
studies
• Oral and dental
